The “Greater Johnstown Young Artists Exhibition” is on display through May 30 in the Goldhaber-Fend Fine Arts Gallery at the ...

MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1 st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development ...

Q1 2025 Earnings Call Transcript May 14, 2025 Monogram Orthopaedics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. Larry Holub: Good afternoon, everyone, and ...

But every now and then something comes along that proves that they are just like the rest of the world in their appetite for ...

First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months Expected by Year-End 2025 Strengthened Leadership Team with the ...

As of March 31, 2025, Aura had cash and cash equivalents and marketable securities totaling $128.0 million. The Company believes its current cash and cash equivalents and marketable securities are ...

Receives FDA Clearance for the mBôs TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business Upda ...

Receives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World’s First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business ...

IND application submission on track for Q2 2025: MBX 4291, a GLP-1/GIP co-agonist prodrug, is being developed as a once-monthly treatment for obesity. The Company expects to submit an IND application ...

Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...